Healthy Inc > Blog > treatment of Falciparum malaria
Posted on:

Why is pyrimethamine given in combination with sulfadoxine?

In the pharmaceutical industry, the combination of Pyrimethamine and Sulfadoxine (famously known by the brand Fansidar) is a classic example of Synergistic Antifolate Therapy.

As a pharmacist and manufacturer, I view this Fixed-Dose Combination (FDC) as a “Sequential Blockade” strategy. These two drugs are given together because they target the same metabolic pathway in the malaria parasite but at two different points, making the treatment significantly more powerful than either drug used alone.

The Mechanism: Sequential Folate Blockade

Parasites, unlike humans, must synthesize their own folic acid to produce DNA and survive. The combination “starves” the parasite through a two-step attack.

Step 1: Sulfadoxine (The PABA Analog): Sulfadoxine inhibits the enzyme dihydropteroate synthase. It mimics PABA (a building block of folate), tricking the parasite and stopping the first stage of folic acid production.

Step 2: Pyrimethamine (The DHFR Inhibitor): Any folate that manages to get past the first block is then targeted by Pyrimethamine. It inhibits dihydrofolate reductase, stopping the final conversion into active folate.

The Result: This “1-2 punch” effectively shuts down DNA synthesis, preventing the parasite from replicating.

Primary Clinical Advantages

  • Potentiation: When used together, the effective dose required for each drug is lower, but the combined killing power is multiplied.

  • Resistance Delay: By attacking two different enzymes, it is much harder for the parasite to develop mutations to survive the treatment.

  • Long Half-Life: Both drugs stay in the blood for a long time (Sulfadoxine ~7–9 days; Pyrimethamine ~4 days). This makes the combination ideal for Intermittent Preventive Treatment (IPTp) in pregnant women in endemic regions.

The Pharmacist’s “Technical Warning”

  • Stevens-Johnson Syndrome (SJS): As a manufacturer, you must highlight the risk of severe skin reactions. Sulfadoxine is a “Sulfa” drug, which can cause life-threatening SJS in sensitive individuals.

  • Folate Deficiency: While the drug is selective for parasites, long-term use can affect human folate levels. It is often co-administered with Folinic Acid in high-dose treatments.

  • Contraindications: Strictly avoid in patients with known sulfonamide (Sulfa) allergies or severe liver/kidney impairment.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai:

  • The “Tender” SKU: This FDC (500mg Sulfadoxine + 25mg Pyrimethamine) is a high-volume product for National Malaria Control Programs in Africa and Southeast Asia.

  • Stability for Export: Sulfadoxine is slightly light-sensitive. Utilizing Alu-Alu blister packaging is the professional standard to ensure a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international health tenders for malaria eradication.

Sulfadoxine Pyrimethamine Tablets

Posted on:

How many tablets of Artesunate should an adult take?

In the pharmaceutical industry, Artesunate is an artemisinin derivative and a critical blood schizontocidal agent. As a pharmacist and manufacturer, I must differentiate between its two primary clinical uses: Oral treatment for uncomplicated malaria and Parenteral treatment for severe malaria.

At your WHO-GMP facility in Mumbai, you likely manufacture the 50 mg or 100 mg tablets, which are governed by strict weight-based dosing protocols.

 Oral Dosage (Uncomplicated Malaria)

For an adult (typically defined as weighing 50 kg or more), Artesunate is rarely used alone; it is almost always part of an Artemisinin-based Combination Therapy (ACT) to prevent resistance.

Day No. of Tablets (50 mg) No. of Tablets (100 mg) Total Daily Dose
Day 1 4 Tablets 2 Tablets 200 mg
Day 2 4 Tablets 2 Tablets 200 mg
Day 3 4 Tablets 2 Tablets 200 mg

  • Standard Rule: The adult dose is 4 mg/kg of body weight, taken once daily for 3 consecutive days.

  • Combination Requirement: This must be taken alongside a partner drug (like Sulfadoxine/Pyrimethamine or Mefloquine) as per the National Anti-Malaria Drug Policy.

  • Parenteral Transition (Severe Malaria)

If the patient was initially treated with injections for severe malaria, the switch to oral tablets happens once they can tolerate food and drink.

  • The “Step-Down” Protocol: After a minimum of 24 hours of injectable Artesunate, the patient must complete a full 3-day course of an oral ACT.

  • Timing: The first oral dose should be taken 8 to 12 hours after the last injection.

Mechanism: Why the 3-Day Rule?

Artesunate is exceptionally fast-acting but has a very short half-life ($<60\text{ minutes}$).

The Quick Kill: It rapidly reduces the parasite biomass in the first 24 hours.

The Clearance: The subsequent doses (Day 2 and 3) ensure that any remaining “dormant” parasites are eliminated as they re-enter the active cycle.

Resistance Prevention: Stopping after 1 or 2 days is the primary cause of treatment failure and drug resistance.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai, here is how to optimize this product for your digital platforms:

  • Packaging USP: For adult patients, we manufacture “Adult Blister Packs” containing 12 tablets of 50 mg (or 6 tablets of 100 mg). This ensures the patient has exactly the right amount for a 3-day course, significantly improving compliance.

  • Dissolution Profile: As a pharmacist, you know that for oral tablets to be effective against malaria, they must disintegrate rapidly ($<15\text{ minutes}$). Highlighting your advanced compression technology is a major selling point for international health NGOs.

  • Dossier Readiness: We provide full CTD/eCTD Dossiers to support your firm in bidding for massive government tenders in Africa and Southeast Asia.

  • Stability for Zone IVb: We utilize Alu-Alu blister packaging to protect the sensitive Artesunate molecule from the high heat and humidity of tropical export markets.

Artesunate Tablets

Add to cart